Previous
Pause
Next
Skip to Navigation
↓
Congresses
Year
Year
Year
-Year
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Researcher
- Any -
Almeida e Silva, Filomena Augusta
Arenal , Raúl
Baptista , Pedro Miguel
Bernechea Navarro, María
Bover Arbós, Pere
Calvo Lacosta, Jorge Hugo
Cantín Mardones, Celia M
Carstensen , Hans-Heinrich
Castro Barrigón, Alberto
Cazcarro Castellano, Ignacio
Cobarrubias Baglietto, Sebastián Felipe
DeMiguel , Daniel
Domínguez Castro, Fernando
Estrada Roger, Ernesto
Ferrio Díaz, Juan Pedro
Gil Hernández, Vanesa
Gracia Lostao, Ana Isabel
Gurauskis , Jonas
Hernández Ainsa, Silvia
Hernández Latas, José Antonio
Hurtado Guerrero, Ramón
Jiménez Schuhmacher, Alberto
Jiménez Jaén, Juan José
Juarez-Perez , Emilio J.
Knoll , Fabien
Köhler , Ralf
Laclaustra , Martín
Lisbona Martín, María Pilar
Mangas-Sánchez , Juan
Martín Duque, Mª del Pilar
Martínez Pérez, María
Martínez Pérez, María José
Martínez-Padilla , Jesús
Millán Gasca, Javier
Montiel , Manuel
Muñoz Soro, José Félix
Olmo , Jose
Ordovás Vidal, Laura
Pardo Jimeno, Julián
Pey Betrán, Jorge
Philippidis , George
Pérez Ibarra , Irene
Ramón García, Santiago
Roque , Carla
Schoorlemmer , Jon
Sola , Daniel
Stavridis , Stelios
Velázquez Campoy, Adrián
Íñiguez Dieste, David
Title
Title
Year
A BICISTRONIC RECOMBINANT ADENOVIRUS CARRYING BOTH P53 AND P16 TUMOR SUPPRESSO GENES FOR TREATMENT OF P53-RESISTANT GLIOMAS.
1998
A NEW TOOL FOR GLIOMA TREATMENT: A MUTANT ADENOVIRUS THAT REPLICATES PREDOMINANTLY IN DIVIDING CELLS WITH ALTERED EXPRESSION OF Rb.
1998
THE ADENOVIRUS E1a GENE IN CANCER GENE THERAPY.
1998
TUMOR SUPPRESOR EFFECT OF THE ADENOVIRUS E1A GENE.
1998
THE ADENOVIRUS E1A GENE IN CANCER THERAPY
1998
INFECTION WITH ADENOVIRUS E1B DEFECTIVES EXERTS A MARKED CYTOPATHIC EFFECT ON MICE CELLS DEFICIENT IN P16, P21, P27 OR P53 GENES
1998
AN ANTITUMOR TREATMENT IN HUMAN CANCER WITH E1B GENE DEFECTIVE ADENOVIRUSES
1998
E2F-DEPENDENT GLIOMA APOPTOSIS IN THE ABSENCE OF TRANSCRIPTIONAL ACTIVATION OF E2F-TARGET GENES
1998
SYNERGISTIC EFFECT OF p53, p53-p16 AND E2F-1 IN GLIOMAS SUGGEST DIFFERENT MECHANISM OF ACTIVATION OF APOPTOSIS.
1998
A NOVEL THERAPEUTIC APPROACH FOR GLIOMAS: AN ADENOVIRUS DESIGN TO REPLICATE EXCLUSIVELY IN Rb-MUTANT CELLS.
1998
A NOVEL THERAPEUTIC APPROACH FOR GLIOMAS: AN ADENOVIRUS DESIGN TO REPLICATE EXCLUSIVELY IN Rb-MUTANT CELLS.
1998
Caracterización genética de la raza porcina Chato Murciano.
1998
Instalación para el estudio de sistemas sostenidos por acelerador
1999
Measuring lateral interactions between adsorbed protein molecules by isothermal titration calorimetry
1999
El proyecto del Laboratorio del Amplificador de Energía: desarrollos y objetivos
1999
Thermodynamic characterization of tripeptide inhibitors of the HIV-1 protease
1999
Estudios neutrónicos y fluidodinámicos de fuentes intensas de neutrones de espalación
1999
A structure-based thermodynamic analysis of inhibitor binding and drug resistance mutations in HIV-1 protease
1999
Caracterización de prototipos de amplificadores de energía de baja potencia
1999
Estudios sobre la Estabilidad Configuracional del Enlace C-Zn
1999
Pages
« primera
‹ anterior
1
2
3
4
5
6
7
8
9
…
siguiente ›
última »